Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Cancer antigen 125 (CA125) can predict ovarian cancer in general practice

CA125 Can Detect Ovarian Cancer in General Practice

And elevated CA125 indicates higher risk for other cancers, especially in women aged ≥50 years
Microvascular endothelial dysfunction is associated with an increased risk for solid-tumor cancer

Test of Vascular Function May Predict Solid-Tumor Cancer Risk

Reactive hyperemia peripheral arterial tonometry index ≤2.0 predicted incidence of solid-tumor cancer
For patients with obesity undergoing bariatric surgery

Cancer Risk Halved With Bariatric Surgery-Linked Weight Loss

Hazard ratio 0.44 for incident cancer with loss of at least 20 to 35 versus <20 percent of total body weight
Exercise should be prescribed for cancer survivors

Exercise Should Be Prescribed to Cancer Survivors

Key stakeholders are urged to create the infrastructure and necessary cultural adaptations
For patients with obesity

Bariatric Surgery in Obese Patients May Lower Cancer Risk

Among genetically predisposed, breast cancer rate higher in those who did not opt for bariatric surgery
Between 2005 and 2015

Number of Cancer Patients Using Gabapentinoids Up Since 2005

Authors say more long-term studies of risks, efficacy of gabapentinoids needed
Patients with monoclonal gammopathy of undetermined significance have increased hospital activity unrelated to hematology for several years before diagnosis

MGUS Patients Have Higher Hospital Activity Before Diagnosis

Increased hospital activity unrelated to hematology seen for years before diagnosis
Survivors of chronic lymphocytic leukemia have an increased risk for second primary malignancy

Risk for Second Primary Malignancy Up in CLL Survivors

SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age
Only half of oncologists who discuss genomic testing with patients report that they often discuss the likely costs of testing and related treatments

Many Oncologists Fail to Discuss Costs of Genomic Testing

About a quarter of oncologists say they rarely, never bring up costs when they discuss genomic testing

October 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2019. This roundup includes...